This topic contains a solution. Click here to go to the answer

Author Question: Abnormal brain levels of dopamine are associated with a. mania and bipolar disorder. b. ... (Read 26 times)

big1devin

  • Hero Member
  • *****
  • Posts: 583
Abnormal brain levels of dopamine are associated with
 
  a. mania and bipolar disorder.
  b. schizophrenia and Parkinson's disease.
  c. Alzheimer's disease and schizophrenia.
  d. Klver-Bucy syndrome and Huntington's chorea.
  e. mood disorder and depression.

Question 2

Drugs that block MAO-A are ________ agonists, whereas MAO-B blockers are ________.
 
  a. nicotinic receptor; muscarinic receptor antagonists
  b. glutamatinergic; glycine receptor agonists
  c. dopamine; norepinephrine antagonists
  d. presynaptic; postsynaptic antagonists
  e. norepinephrine; dopamine agonists



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

uniquea123

  • Sr. Member
  • ****
  • Posts: 311
Answer to Question 1

Answer: b. schizophrenia and Parkinson's disease.

Answer to Question 2

Answer: e. norepinephrine; dopamine agonists




big1devin

  • Member
  • Posts: 583
Reply 2 on: Jun 22, 2018
:D TYSM


jackie

  • Member
  • Posts: 324
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Thyroid conditions cause a higher risk of fibromyalgia and chronic fatigue syndrome.

Did you know?

About 3% of all pregnant women will give birth to twins, which is an increase in rate of nearly 60% since the early 1980s.

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

Acetaminophen (Tylenol) in overdose can seriously damage the liver. It should never be taken by people who use alcohol heavily; it can result in severe liver damage and even a condition requiring a liver transplant.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library